Advocacy intelligence hub — real-time data for patient organizations
Amryt Pharma — PHASE4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — PHASE2
Amryt Pharma — PHASE3
Cambridge University Hospitals NHS Foundation Trust — NA
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Rebecca J Brown, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 Bethesda, Maryland
Abhimanyu Garg, MD, MD
University of Texas Southwestern Medical Center
📍 DALLAS, TX
Elif Oral, MD, MD
University of Michigan
📍 ANN ARBOR, MI
Elif A Oral, MD, MD
University of Michigan
📍 ANN ARBOR, MI
David Savage, Prof.
University of Cambridge Metabolic Research Laboratories
Lori Hartnett, MA, CCC-SLP/L
Amryt Pharmaceuticals DAC
📍 OMAHA, NE